采用袖套优先技术预防II型内漏的腹主动脉瘤腔内修复术中期结局
本研究回顾性分析了2016至2022年在东京慈惠会医科大学医院接受EVAR的91例腹主动脉瘤患者,其中56例采用袖套优先技术(CFT),35例采用侧支栓塞(SBE)。CFT组手术时间和辐射暴露均低于SBE组,中期瘤囊缩小率、再干预率和动脉瘤相关死亡率无显著差异。作者认为,在解剖条件合适时,CFT可作为SBE预防II型内漏的替代方案。
要点
- CFT组手术时间中位数10分钟,短于SBE组的25分钟(P < .05)。
- CFT组辐射暴露中位数1455 mGy,低于SBE组的2353 mGy(P < .05)。
- 两组瘤囊缩小率、再干预率及动脉瘤相关死亡率无显著差异。
核心结论
- CFT可行,且较SBE手术时间更短、辐射暴露更低,中期结局(包括瘤囊缩小率)与SBE相当。
- 作者认为,若解剖条件合适,CFT可作为EVAR中预防II型内漏的SBE替代方案。
研究设计与样本
- 回顾性研究,纳入2016至2022年在东京慈惠会医科大学医院接受EVAR并采用CFT或SBE预防II型内漏的腹主动脉瘤患者。
- 共纳入91例患者,其中CFT组56例,SBE组35例。
主要发现
- CFT组和SBE组每目标血管的技术成功率分别为97.8%和91.8%,临床成功率分别为91.0%和100%。
- CFT组手术时间中位数10分钟(IQR 6-14) vs SBE组25分钟(IQR 18.5-45),P < .05。
- CFT组辐射暴露中位数1455 mGy(IQR 840-2634) vs SBE组2353 mGy(IQR 1552-3586),P < .05。
- 中位随访25个月(IQR 12.5-47)期间,瘤囊缩小率CFT组37.5% vs SBE组40.0%,P = .812。
- 12个月和36个月免于再干预率:CFT组96.2%和91.4% vs SBE组100%和89.5%,log-rank P = .761;36个月免于动脉瘤相关死亡率两组均为100%,log-rank P = .440。
临床怎么用
- 作者认为,若解剖条件合适,CFT可作为SBE的替代方案用于EVAR中预防II型内漏。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to evaluate the initial and midterm outcomes of endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) using the cuff-first technique (CFT) to prevent type II endoleak (T2EL). METHODS: CFT involves deploying an aortic cuff inside the AAA to cover the ostium of the aortic side branch vessels before deploying the main body. We performed a retrospective review of all patients undergoing EVAR with CFT or side branch embolization (SBE) for AAAs at The Jikei University Hospital between 2016 and 2022. Primary endpoint was the rate of aneurysm sac shrinkage. Secondary endpoints were procedure time, radiation exposure, technical and clinical success rates, occurrence of T2EL, and freedom from reintervention or aneurysm-related death. RESULTS: Of 406 patients who underwent EVAR for AAAs, CFT was utilized in 56 (CFT group) and SBE in 35 (SBE group); all 91 patients were included in this study. There were no differences in patient demographics between groups, but there were differences in patency rate of the inferior mesenteric artery and absent intraluminal thrombus. The technical success rate per target vessel in the CFT and SBE group was 97.8% and 91.8%, and the clinical success rate was 91.0% and 100%, respectively. The median procedure time was shorter for CFT than for SBE: CFT, 10 (interquartile range [IQR], 6-14) minutes vs SBE, 25 (IQR, 18.5-45) minutes; P < .05), and median radiation exposure was lower for CFT than for SBE (CFT, 1455 (IQR, 840-2634) mGy vs SBE, 2353 (IQR, 1552-3586) mGy; P < .05). During the median follow-up of 25 months (IQR, 12.5-47 months), sac shrinkage occurred at similar rates in both groups (CFT, 37.5% vs SBE, 40.0%; P = .812), and there were no differences in freedom from reintervention (CFT, 96.2% and 91.4% at 12 and 36 months vs SBE, 100% and 89.5% at 12 and 36 months; log-rank P = .761) and freedom from aneurysm-related death (100% at 36 months in both groups; log-rank P = .440). The odds ratio of CFT vs SBE for sac regression was calculated by adjusting for inferior mesenteric artery patency and absent intraluminal thrombus, resulting in no statistical significance (odds ratio, 1.231; 95% confidence interval, 0.486-3.122). CONCLUSIONS: CFT is feasible with a shorter procedure time and lower radiation exposure than SBE and comparable mid-term outcomes, including sac shrinkage rate, compared with SBE. We believe that CFT, if anatomically suitable, is an alternative to SBE for the prevention of T2EL during EVAR.
引用
- Ozawa H, Ohki T, Shukuzawa K, et al. Midterm outcomes of endovascular repair for abdominal aortic aneurysm using the cuff-first technique to prevent type II endoleaks. J Vasc Surg. 2024. PMID: 38631517. doi:10.1016/j.jvs.2024.04.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。